Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series
Publication date
2023-05
Authors
Achten, Roselie E
Dekkers, Coco C
Bakker, Daphne S
van Luijk, Chantal
de Graaf, M
van Wijk, Femke
de Boer, Joke
de Bruin-Weller, Marjolein
Thijs, Judith
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Keywords
atopic dermatitis, autoimmunity, basic mechanisms, dermatology, ocular allergy, Immunology and Allergy, Immunology, Letter
Citation
Achten, R, Dekkers, C, Bakker, D, van Luijk, C, de Graaf, M, van Wijk, F, de Boer, J, de Bruin-Weller, M & Thijs, J 2023, 'Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease : Preliminary case series', Clinical and Experimental Allergy, vol. 53, no. 5, pp. 586-589. https://doi.org/10.1111/cea.14305